Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

IFEANYI ISAIAH

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1093936551
CMS profile
1291666
Location
PEMBROKE PINES, FL

General Payments · PY2018–2024

$839.71

  • Reported across 38 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$341.71

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $341.71 15

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $43.31 2
PY2019 $69.69 4
PY2020 $90.09 4
PY2021 $92.68 4
PY2022 $112.71 4
PY2023 $89.52 5
PY2024 $341.71 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Ardelyx, Inc. $13.70 03/14/2024 Food and Beverage Undisputed 01/23/2026 1146686151 CMS
Ardelyx, Inc. $22.28 11/06/2024 Food and Beverage Undisputed 01/23/2026 1146686153 CMS
AstraZeneca Pharmaceuticals LP $24.18 02/22/2024 Food and Beverage Undisputed 01/23/2026 1104337340 CMS
AstraZeneca Pharmaceuticals LP $22.83 09/10/2024 Food and Beverage Undisputed 01/23/2026 1104491466 CMS
Bayer Healthcare Pharmaceuticals Inc. $30.88 04/09/2024 Food and Beverage Undisputed 01/23/2026 1086157770 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.51 04/18/2024 Food and Beverage Undisputed 01/23/2026 1117871779 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.83 06/12/2024 Food and Beverage Undisputed 01/23/2026 1117871781 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.34 11/13/2024 Food and Beverage Undisputed 01/23/2026 1117871777 CMS
CALLIDITAS THERAPEUTICS US INC. $20.32 01/11/2024 Food and Beverage Undisputed 01/23/2026 1141507936 CMS
CALLIDITAS THERAPEUTICS US INC. $22.81 03/07/2024 Food and Beverage Undisputed 01/23/2026 1141510971 CMS
Mallinckrodt Hospital Products Inc. $32.00 02/09/2024 Food and Beverage Undisputed 01/23/2026 1145086303 CMS
Mallinckrodt Hospital Products Inc. $33.37 03/20/2024 Food and Beverage Undisputed 01/23/2026 1145086308 CMS
Mallinckrodt Hospital Products Inc. $23.15 05/23/2024 Food and Beverage Undisputed 01/23/2026 1145086312 CMS
Mallinckrodt Hospital Products Inc. $28.16 10/03/2024 Food and Beverage Undisputed 01/23/2026 1145086316 CMS
Novartis Pharmaceuticals Corporation $22.35 08/29/2024 Food and Beverage Undisputed 01/23/2026 1086953069 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.